Article Text
PDF
Abstract
Introduction/Background It is very controversial whether routine appendectomy should be performed as a part of surgery for mucinous borderline ovarian tumors (mBOTs) and invasive mucinous ovarian tumours (IMOT) as the exact magnitude of the benefits of appendectomy are unclear. So current study has been conducted to determine the frequency of appendiceal involvement in patients who undergo surgery for mBOTs and to determine associated morbidity and recurrence after surgery.
Methodology Hospital database was searched for all the patients from Jan 2008 to Dec 2022, whose final diagnosis was mBOTs. All women who have been operated for mBOTs were included in the study. Patients who have had prior appendectomy and those with mucinous ovarian cancer were excluded. Descriptive analysis was performed for study variables. Mean ± standard deviation (SD) and median (interquartile range, IQR) was calculated for quantitative variables and frequency (%) was calculated for qualitative variables. Survival curve was made according to the Kaplan-Meier method.
Results Ninety cases were identified from Cancer registry whose final diagnosis was mBOTs. Of those, thirty nine cases were excluded as they didn’t fulfill the inclusion criteria. Fifty one patients were finally selected for the study. Of 51 patients, appendectomy was not performed in three patients and the reason was not mentioned in the record. Appendix was macroscopically abnormal in only 2 patients. None of the patients were diagnosed with mucinous borderline tumor of the appendix in our study. Appendectomy itself was not associated with any complications. Only one patient with mBOT had recurrence after 4 months of surgery which was surgically treated and no patient died during median follow up of 36 months.
Conclusion If appendix is grossly normal looking then appendectomy seems to be an un-necessary procedure in patients of mBOTs.
Disclosures No conflict of interest.
No source of funding.
